Marco Prado trained in neurochemistry with Dr. Marcus Vinicius Gomez (Brazil) and Dr. Brian Collier (Canada) and holds the Ph.D. degree from the Federal University of Minas Gerais (Brazil, 1993). He serves as a Scientist at the Robarts Research Institute and as a Professor at the Department of Physiology and Pharmacology and Department of Anatomy and Cell Biology, University of Western Ontario, Canada (since 2008). Prior to his recruitment to Robarts, for which he was awarded a Recruitment Grant from PrioNet-Canada, he served as an Associate Professor at the Federal University of Minas Gerais (Brazil, 1994-2008). He worked also as a Visiting Scientist with Dr. Marc Caron at Duke University during a sabbatical period (2003-2004). He served as a Section Editor in Cell Biology for the Brazilian Journal of Medical and Biological Research (2003-2008) and currently serves in the Editorial Board of Journal of Neurochemistry as a Handling Editor. He is the elected scientific representative in the Board of Directors of PrioNet-Canada (2011-2012). Marco Prado received multiple junior (1994-2000) and then senior (2000-2008) competitive fellowships from the National Science Foundation (CNPq-Brazil). He also received a fellowship from IBRO (2003) and was nominated a Guggenheim fellow by the John Simon Guggenheim Memorial Foundation (2004-2005). Research in the Prado laboratory focuses on mechanisms of cellular communication in neurodegenerative diseases. He has developed novel genetically modified mice to model neurochemical deficits in dementia, with particular focus on Alzheimer’s disease. He has also involved in identifying novel therapeutic targets in prion diseases by focusing on how the prion protein regulates cell signaling. He published over 90 manuscripts in journals such as Neuron, Journal of Neuroscience, Faseb Journal, Journal of Biological Chemistry, and Journal of Neurochemistry.
Biography Updated on 1 November 2011